Cheguo Cai

1.6k total citations · 1 hit paper
38 papers, 1.1k citations indexed

About

Cheguo Cai is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Cheguo Cai has authored 38 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 16 papers in Oncology and 6 papers in Cancer Research. Recurrent topics in Cheguo Cai's work include Cancer Cells and Metastasis (11 papers), RNA modifications and cancer (6 papers) and Cancer-related molecular mechanisms research (5 papers). Cheguo Cai is often cited by papers focused on Cancer Cells and Metastasis (11 papers), RNA modifications and cancer (6 papers) and Cancer-related molecular mechanisms research (5 papers). Cheguo Cai collaborates with scholars based in China, United States and Germany. Cheguo Cai's co-authors include Yi Arial Zeng, Qing Yu, Li Yang, Xiaobing Dong, Daisong Wang, Xiao‐Ou Zhang, Lingxian Zhang, Qiping Zheng, Ruoxuan Hei and Xuan Wu and has published in prestigious journals such as Nature, Genes & Development and Nature Cell Biology.

In The Last Decade

Cheguo Cai

35 papers receiving 1.0k citations

Hit Papers

CDK inhibitors in cancer therapy, an overview of recent d... 2021 2026 2022 2024 2021 50 100 150 200

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Cheguo Cai China 15 663 442 230 147 118 38 1.1k
Yu-Mei Feng China 21 847 1.3× 466 1.1× 383 1.7× 146 1.0× 83 0.7× 41 1.3k
Eneda Toska United States 17 855 1.3× 263 0.6× 210 0.9× 227 1.5× 122 1.0× 36 1.1k
Annika Wulf-Goldenberg Germany 16 779 1.2× 352 0.8× 297 1.3× 112 0.8× 70 0.6× 27 1.2k
Bethany Smith United States 10 530 0.8× 360 0.8× 274 1.2× 168 1.1× 57 0.5× 16 863
Michelle Van Scoyk United States 15 896 1.4× 226 0.5× 245 1.1× 141 1.0× 64 0.5× 27 1.2k
Wenting Zhu China 15 831 1.3× 267 0.6× 125 0.5× 129 0.9× 98 0.8× 38 1.1k
Daniela Annibali Belgium 18 601 0.9× 295 0.7× 257 1.1× 104 0.7× 42 0.4× 29 1.0k
Chao Dai China 16 807 1.2× 352 0.8× 266 1.2× 57 0.4× 69 0.6× 33 1.1k
Leah M. Cook United States 17 496 0.7× 355 0.8× 190 0.8× 156 1.1× 135 1.1× 35 1.0k

Countries citing papers authored by Cheguo Cai

Since Specialization
Citations

This map shows the geographic impact of Cheguo Cai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cheguo Cai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cheguo Cai more than expected).

Fields of papers citing papers by Cheguo Cai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cheguo Cai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cheguo Cai. The network helps show where Cheguo Cai may publish in the future.

Co-authorship network of co-authors of Cheguo Cai

This figure shows the co-authorship network connecting the top 25 collaborators of Cheguo Cai. A scholar is included among the top collaborators of Cheguo Cai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cheguo Cai. Cheguo Cai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yang, Jian, et al.. (2025). Umbilical cord mesenchymal stem cell-derived exosomes promote wound healing and skin regeneration via the regulation of inflammation and angiogenesis. Frontiers in Bioengineering and Biotechnology. 13. 1641709–1641709.
2.
Zhang, Mengna, Lingxian Zhang, Jie Liu, et al.. (2025). Mammary stem cells: from molecular cues to orchestrated regulatory mechanisms and its implications in breast cancer. Journal of genetics and genomics. 52(12). 1421–1437.
3.
Wen, Shanshan, Ran Zheng, Cheguo Cai, & Wei Jiang. (2025). Chemical-based epigenetic reprogramming to advance pluripotency and totipotency. Nature Chemical Biology. 21(5). 635–647. 4 indexed citations
4.
Yu, Liya E., Wei Wei, Jian Lv, et al.. (2024). FABP4-mediated lipid metabolism promotes TNBC progression and breast cancer stem cell activity. Cancer Letters. 604. 217271–217271. 16 indexed citations
6.
Yan, Chaojun, Zirui Zhou, Qifang Li, et al.. (2023). A cleaved METTL3 potentiates the METTL3–WTAP interaction and breast cancer progression. eLife. 12. 10 indexed citations
7.
Lv, Jian, Yimeng Hu, Lili Li, et al.. (2023). Targeting FABP4 in elderly mice rejuvenates liver metabolism and ameliorates aging-associated metabolic disorders. Metabolism. 142. 155528–155528. 26 indexed citations
8.
Yang, Yulin, Nianchao Zhang, Chuan Gao, et al.. (2023). Estrogen receptor α-mediated signaling inhibits type I interferon response to promote breast carcinogenesis. Journal of Molecular Cell Biology. 15(7). 5 indexed citations
9.
Yan, Chaojun, Zirui Zhou, Qifang Li, et al.. (2023). A cleaved METTL3 potentiates the METTL3–WTAP interaction and breast cancer progression. eLife. 12. 6 indexed citations
10.
Ye, Zi, et al.. (2023). Macrophages maintain mammary stem cell activity and mammary homeostasis via TNF-α-PI3K-Cdk1/Cyclin B1 axis. npj Regenerative Medicine. 8(1). 23–23. 11 indexed citations
12.
Li, Xiao, Jinpeng Li, Liming Xu, et al.. (2022). CDK16 promotes the progression and metastasis of triple-negative breast cancer by phosphorylating PRC1. Journal of Experimental & Clinical Cancer Research. 41(1). 149–149. 29 indexed citations
13.
Xu, Meng, et al.. (2022). AHNAK2 is a biomarker and a potential therapeutic target of adenocarcinomas. Acta Biochimica et Biophysica Sinica. 54(11). 1708–1719. 2 indexed citations
14.
Zhang, Mengna, Lingxian Zhang, Xiao Li, et al.. (2022). CDK14 inhibition reduces mammary stem cell activity and suppresses triple negative breast cancer progression. Cell Reports. 40(11). 111331–111331. 17 indexed citations
15.
Wang, Lijie, Wei Xue, Hongxia Zhang, et al.. (2021). Eliminating base-editor-induced genome-wide and transcriptome-wide off-target mutations. Nature Cell Biology. 23(5). 552–563. 71 indexed citations
16.
Wang, Ruirui, Wei Wei, Yu Zhou, et al.. (2021). Programmed Cell Death Ligand 1 Is Enriched in Mammary Stem Cells and Promotes Mammary Development and Regeneration. Frontiers in Cell and Developmental Biology. 9. 772669–772669. 7 indexed citations
17.
Wu, Ting, Cheguo Cai, Wenqian Song, et al.. (2020). A novel function of R-spondin1 in regulating estrogen receptor expression independent of Wnt/β-catenin signaling. eLife. 9. 22 indexed citations
18.
Cai, Cheguo, et al.. (2019). Amphiregulin mediates the hormonal regulation on Rspondin-1 expression in the mammary gland. Developmental Biology. 458(1). 43–51. 12 indexed citations
19.
Wang, Lingli, Ruirui Wang, Zi Ye, et al.. (2018). PVT1 affects EMT and cell proliferation and migration via regulating p21 in triple-negative breast cancer cells cultured with mature adipogenic medium. Acta Biochimica et Biophysica Sinica. 50(12). 1211–1218. 29 indexed citations
20.
Zhang, Rui, Huimin Ma, Yuan Gao, et al.. (2018). Th-POK regulates mammary gland lactation through mTOR-SREBP pathway. PLoS Genetics. 14(2). e1007211–e1007211. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026